Zackheim Herschel S
Department of Dermatology, University of California-San Francisco, California, Menlo Park 94025, USA.
Dermatol Ther. 2003;16(4):299-302. doi: 10.1111/j.1396-0296.2003.01641.x.
The University of California, San Francisco (UCSF), experience with topical carmustine (BCNU) in the treatment of approximately 200 patients with mycosis fungoides (MF) is summarized. Topical BCNU is an effective treatment for patch- and early plaque-stage MF. Side-effects are usually not a major deterrent to continuation of therapy.
总结了加利福尼亚大学旧金山分校（UCSF）使用局部卡莫司汀（BCNU）治疗约200例蕈样肉芽肿（MF）患者的经验。局部BCNU是斑块期和早期斑片期MF的有效治疗方法。副作用通常不会成为继续治疗的主要障碍。
